Abstract
IntroductionSafe and effective pharmacological treatment is of paramount importance for treating severe psoriasis. Brodalumab, a monoclonal antibody against interleukin (IL) 17 receptor A, was granted marketing authorisation in the EU...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have